BWY Labs

Created this app for Muslims to plan Ramadan. This app has following core features: -Prayer times with alarm -3D Qibla Direction -Sunnah Habit Tracker -Suhoor and Iftar Timings -Quran reading Schedule -Today's Log -Hadith of the day

@TheValueTrade $iren for sure

You can only buy one... You have to hold 18 months.... $NBIS or $IREN

@AlphaTrader00 What’s your target now?

Okay chat, I have some good news and bad news The bad news is I sold all my $IREN 2 weeks ago at $61. But the good news is that I went long $IREN again this week at $46 and I'm ready for the lift. Feel free to follow along for more Alpha. P.S. Do you hold your IREN or trade it?

🚀 $NVDA x $IREN 🟢 $75.2B — NVDA Q1 Data Center Revenue 🟢 $91B — NVDA Q2 Revenue Guidance 🟢 $3.4B — IREN AI Cloud Contract with NVDA 🟢 $2.1B — NVDA Equity Investment Option in IREN 🟢 5GW — IREN Power & Infrastructure Pipeline #NVDA #IREN #AI

$NVDA just proved the AI infrastructure boom is accelerating! With a record $75.2B in Data Center revenue and a mind-blowing $91B guidance for Q2, the demand for compute is completely unsatiable. 🚀 This is incredibly BULLISH for $IREN! ⚡️

Nvidia's guidance: $NVDA Guidance is IN!🔮 Nvidia is forecasting a massive **$91 Billion** in revenue for fiscal Q2 (plus or minus 2%), handily beating Wall Street's expectations of $87.36B. The AI demand isn't slowing down anytime soon. 🚀 #Nvidia #NVDA #Earnings #Stocks

@arthritisfinger Never bet earnings

$HIMS > what is your takeaway guys?

$Hims & Hers Q1 2026 Earnings 🚀 • Revenue: $608M (+4% YoY) • Subscribers: 2.58M (+9%) • Raised full-year guidance International exploding, branded GLP-1 pivot gaining traction, and Eucalyptus deal set to supercharge global growth. This is a high-conviction platform play in

@wave3trades Very risky at earnings. I have witnessed many hims earnings, always went down

$HIMS is starting to get boring again But that's what usually happens before a big move Reclaim $29, reclaim the 200dma, hit wave 3 target at $41 nfa

@TheValueTrade @himshouse bcoz he is shortie

@himshouse Why do you share news that's old?

🚨 BREAKING: AMAZON TO OFFER SAME-DAY DELIVERY FOR OZEMPIC PILL Will be available in nearly 3,000 cities, expanding to 4,500 by end of year Will also provide pickup through kiosks at select One Medical locations $AMZN $NVO $HIMS

@TheDrugMoney The last four earnings had a brutal negative effect on the stock price.

$HIMS earnings Monday is the Declaration of Independence.

@TheLongInvest It always went negative on earnings as I followed all earnings of this stock last year

$HIMS Tight bullish wedge formed leading into Earnings on Monday with strong catalysts set to be revealed in this report.... Don't be the liquidity Add.

@arthritisfinger @himshouse 35 would be easily achieved in this week

@himshouse 35 maybe by end of May. Triple digits in the next 12-24 months 👀 $HIMS

J.P. MORGAN INITIATES $HIMS PRICE TARGET: $35 RATING: OVERWEIGHT "We think the recent Novo partnership could mark a turning point, removing a significant legal overhang and positioning HIMS as a platform that offers branded, generic, and compounded products" "HIMS recently announced that it’s on track for 100k+ monthly Wegovy prescriptions. We estimate this implies a ~$350–400M annual revenue run-rate and compares to ~250k GLP-1 subscribers pre-Novo." "We think HIMS’ weight loss specialty can still grow this year, and we expect branded and compounded contribution dollars to be similar." "Peptide legalization expands TAM… Consumer interest in peptides has surged in recent years, and we believe HIMS is well positioned to be an early mover given its ownership of US peptide manufacturing and compounding facilities." "We believe peptides, which pharma cannot patent, have the potential to be a meaningful new specialty and source of upside to our model in 2027+." h/t @DustinHuntwn

@StockTrader_Max Not gonna happen

$HIMS For those who are interested in the short term outlook for Hims, I still think that lower prices come next before the breakout higher towards +$40 a share 🎯 A pretty standard ABC correction in playing out here, we are likely in wave C of the correction and still need to post one more lower low to confirm this correction is complete 🤝🏼 Im looking for the gap to close from Friday's session, followed by an undercut of the lows at $27 a share from Thursday. For those who are wanting to add more shares, the $25-$27 range is a great zone to buy, I still have some dry powder which I will look to put to work at this price zone.. Once this ABC correction is complete, +$40 prices come next for the wave 3 target🎯

$HIMS +10% HOT PEPTIDE SUMMER IS COMING 🌶️

$HIMS is down 15%. Firstly, a 10% gain was lost after LLY news. Now another 5%.

@StockTrader_Max You missed your 27$ target

$HIMS SHORT SQUEEZZE CAN ACTUALLY HAPPEN NOW 📈🚀

@StockTrader_Max I think with current FOMO, it will not hit 27-24 range before earning day. HIMS always brutal on earnings, may be we hit on that day

$HIMS I still would not be chasing this stock here above $30 a share... I am one of the biggest bulls in $HIMS, the past week has been crazy with the stock moving +50%... This as a result has brought lots of attention and lead to many buying due to FOMO. I would wait for a dip to the green box between $27-$24 a share to buy this stock, I would not FOMO in here. It pays to be patient 🤝🏼📈

$HIMS is a stock that covered all my losses during the US-Iran conflict.

@YodaStockInvest 500$ by 2030

What’s your $HIMS price target now that we have the $NVO lawsuit shit out of the way? Makes a massive difference imo. $100+ by 2030.

@_saaeed_7 @voided As per many reports, it’s shariah compliant

@voided If company is doing interests in keeping the money in the bank and getting profits from interest it is prohibited in my religion there for I will avoid stock as much as possible .

$33,000 in Sandisk 1 year ago is $1,023,000 today.